EGFR and liver cancer: Knockdown of integrin β1 could slow down liver cancer progression by inhibiting MET proto-oncogene, receptor tyrosine kinase (MET) and epidermal growth factor receptor signaling (Bogorad et al., 2014; Speicher et al., 2014).